In ACS, prasugrel reduces 30-day MACE and mortality vs. ticagrelor or clopidogrel; no differences for major bleeding.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 32926820.
- Also identified by DOI 10.7326/ACPJ202009150-027.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Baldetti L, Melillo F, Moroni F, et al. <b>Meta-analysis comparing P2Y12 inhibitors in acute coronary syndrome.</b> Am J Cardiol. 2020;125;1815-22. 32305225.
Medical subject headings
- Acute Coronary Syndrome